Philip Morris

PM

Market cap $281B

The Dividend Income Accelerator Portfolio emphasizes high-quality companies with sustainable dividends, strong balance sheets, and attractive valuations to optimize risk-adjusted returns. I prioritize a diversified mix of ETFs and individual stocks across sectors, balancing dividend income, growth, and capital appreciation while mitigating downside risk. Key metrics include a 3.75% weighted average dividend yield, low payout ratios, and low beta factors, supporting long-term portfolio resilience.

Philip Morris International's Earnings Preview: I'm Not Buying

For nearly a decade, pension funds and major endowments blacklisted cigarette makers under strict sustainability mandates.

Investors are taking a closer look at companies as they shift away from cigarettes.

Altria maintains strong domestic dominance through its Marlboro brand and generates significant free cash flow from its U.S. operations. Philip Morris International is aggressively expanding its global smoke-free portfolio with brands like IQOS and ZYN in over 100 markets.

Federal regulator gives Philip Morris International a win for nicotine pouches.

The FDA will allow 20 Philip Morris-owned Zyn nicotine pouch products to carry a modified-risk claim saying switching from cigarettes lowers the risk of several smoking-related diseases. The decision gives Philip Morris a major marketing win for one of the fastest-growing nicotine products as cigarette sales decline in the U.S.

STAMFORD, CT--(BUSINESS WIRE)--Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke,.

Altria maintains a dominant position in the U.S. tobacco market with industry-leading net margins and a massive domestic distribution network. Philip Morris International is leading the global shift to smoke-free products with its Iqos and ZYN platforms across more than 100 markets.

The U.S. Food and Drug Administration proposed a rule on Friday that would require foreign tobacco product makers to ​register their facilities and list products sold in the country.